PDC*line Pharma picks up $22.2 mln Series B
PDC*line Pharma, a French and Belgian clinical-stage biotech company, has raised $22.2 million in Series B funding.
PDC*line Pharma, a French and Belgian clinical-stage biotech company, has raised $22.2 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination